Implementing and Optimizing Biosimilar Use at Mayo Clinic

National trends in prescription drug expenditures and projections for 2021

(2021) Eric M Tichy et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Home Dialysis in the Coronavirus Disease 2019 Era

(2020) Preethi Yerram et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

National Health Care Spending In 2019: Steady Growth For The Fourth Consecutive Year

(2020) Anne B. Martin et al.   HEALTH AFFAIRS

The Clinical Implications of Nocebo Effects for Biosimilar Therapy

(2019) Luana Colloca et al.   Frontiers in Pharmacology

Longer-Term Durability of Using Default Options in the Electronic Health Record to Increase Generic Prescribing Rates

(2018) David Olshan et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Can biosimilars help achieve the goals of US health care reform?

(2017) Ralph Boccia et al.   Cancer Management and Research

Pharmacoeconomics of Biosimilars: What Is There to Gain from Them?

(2016) Filipe C. Araújo et al.   Current Rheumatology Reports

Clinical experience with Zarzio® in Europe: what have we learned?

(2013) Pere Gascón et al.   SUPPORTIVE CARE IN CANCER